Press ReleaseBofA Securities Asia Forum Gathers Global Investors Amid Surge in Hedge Funds Allocations Key points BofA Securities hosted its fourth annual Asia Alternatives Forum, bringing… CISION PRNewswireJune 1, 2026
Traveloka 6.6 Mid Year Sale: Up to S$66 Off Flights, Hotels and Attractions for Singapore Travelers Traveloka’s 6.6 Mid Year Sale Unlocks $66 Sitewide Discounts and 1-for-1 Attraction… CISION PRNewswireJune 1, 2026
Deloitte appoints Robert Hillard as Asia Pacific Chief Executive Officer HONG KONG, June 1, 2026 /PRNewswire/ — Deloitte Asia Pacific today announced… CISION PRNewswireJune 1, 2026
Press ReleaseTechUOB and FPT sign MoU to advance AI, technology transformation and financial innovation opportunities SINGAPORE, June 1, 2026 /PRNewswire/ — UOB and global technology corporation FPT have… CISION PRNewswireJune 1, 2026
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept First-line NSCLC – Compelling Activity Across All PD-L1 SubgroupsIn first-line non-small cell… CISION PRNewswireJune 1, 2026
Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting SHANGHAI, June 1, 2026 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code:… CISION PRNewswireJune 1, 2026
Press ReleaseImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO SUZHOU, China, June 1, 2026 /PRNewswire/ — ImmVira Group ("ImmVira") today announced… CISION PRNewswireJune 1, 2026
Press Release2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC IBI363 in combination with chemotherapy demonstrated encouraging efficacy signals and manageable safety… CISION PRNewswireJune 1, 2026
